Utilization of Diagnostic Studies in the Pretreatment Evaluation of Invasive Cervical Cancer in the United States: Results of Intergroup Protocol ACRIN 6651/GOG 183
Marco A. Amendola(Miami Transplant Institute), Constantine Gatsonis(Brown University), Donald G. Mitchell(Thomas Jefferson University), James V. Fiorica(Moffitt Cancer Center), S. Dennis(Memorial Sloan Kettering Cancer Center), Bradley S. Snyder(Memorial Sloan Kettering Cancer Center), Harry J. Long(Memorial Sloan Kettering Cancer Center), Hedvig Hricak(Memorial Sloan Kettering Cancer Center)
Cited by 80
Related Papers
CT Angiography for Safe Discharge of Patients with Possible Acute Coronary Syndromes
|New England Journal of Medicine|2012|707
Cost-Effectiveness of CT Screening in the National Lung Screening Trial
|New England Journal of Medicine|2014|550
LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
|Hepatology|2014|485
Early Invasive Cervical Cancer: Tumor Delineation by Magnetic Resonance Imaging, Computed Tomography, and Clinical Examination, Verified by Pathologic Results, in the ACRIN 6651/GOG 183 Intergroup Study
|Journal of Clinical Oncology|2006|308
Radiotheranostics: a roadmap for future development
|The Lancet Oncology|2020|306